REFERENCES
S. Moncada, R. M. S. Palmer, and E. A. Higgs, Pharmacol. Rev., 43, 109–141 (1991).
M. A. Marletta, J. Med. Chem., 37, 1899–1921 (1994).
O. W. Griffith and D. J. Stuehr, Annu. Rev. Physiol., 57, 707–736 (1995).
V. G. Granik, S. Yu. Ryabova, and N. B. Grigor'ev, Usp. Khim., 66(8), 792–807 (1997).
A. F. Vanin, Biokhimiya, 63(7), 924–938 (1998).
I. S. Severina, Biokhimiya, 63(7), 939–947 (1998).
E. B. Men'shikova, N. K. Zenkov, and V. P. Reutov, Biokhimiya, 65(4), 485–503 (2000).
Nitric Oxide. Basic Research and Clinical Application, R. J. Gryglewsky, and P. Minuz (eds.), IOS Press, Amsterdam, Berlin, Oxford, Tokyo, Washington, DC (2001).
D. Voet and J. G. Voet, Biochemistry, 2th Ed., John Wiley and Sons Inc., New York, Chichester, Brisbane, Toronto, Singapore (1995), p. 1290.
F. Murad, Neurotransmissions, X(2), 1–4 (1994).
H. Al-Sa'Doni and A. Ferro, Clin. Sci., 98, 507–520 (2000).
M. Feelish, J. Cardiovas. Pharm., 17(Suppl. 3), 25–33 (1991).
V. P. Reutov, E. G. Sorokina, V. E. Okhotin, and N. S. Kositsyn, Cyclic Transformations of Nitrogen Oxide in Mammals [in Russian], Nauka, Moscow (1998).
G. Wu and S. M. Morris, Biochem. J., 336, 1–17 (1998).
G. Wu, P. K. Devis, N. E. Flynn, et al., J. Nutr., 127, 2342–2349 (1997).
G. Wu, J. Nutr., 128, 1249–1252 (1998).
H. K. Berthold, R. J. Reeds, and P. D. Klein, Clin. Exp. Metab., 44, 466–479 (1995).
A. Leninger, Principles of Biochemistry, Worth, New York (1982).
V. G. Granik and N. B. Grigor'ev, Izv. Ross. Akad. Nauk, Ser. Khim., No. 8, 1268–1313 (2002).
V. G. Granik and N. B. Grigor'ev, Izv. Ross. Akad. Nauk, Ser. Khim., No. 11, 1819–1841 (2002).
P. G. Wang, M. Xian, X. Tang, et al., Chem. Rev., 102, 1091–1139 (2002).
S. M. Morris, D. K. Nakayama, A. K. Nussler, et al., The Biology of Nitric Oxide, Vol. 4, Enzymology, Biology and Immunology, S. Moncada, M. Feelish, R. Busse, E. A. Higgs (eds.), Portland Press, London (1994), pp. 301–303.
M. Hecker, W. C. Sessa, H. J. Harris, et al., Proc. Natl. Sci. USA, 87, 8612–8616 (1990).
S. M. Morris and T. R. Billiar, Am. J. Physiol., 266, E829–E839 (1994).
L. Xie and S. S. Gross, J. Biol. Chem., 272, 16624–16650 (1997).
G. Li, S. Regunathan, J. Barrow, et al., Science, 263, 966–969 (1994).
M. D. Mashkovskii, Drugs [in Russian], Torsing, Kharkov (1997).
M. D. Mashkovskii, Drugs of the XXI Century [in Russian], Novaya Volna, Moscow (1998).
J. Satriano, S. Matsufuji, Y. Marakami, et al., J. Biol. Chem., 273, 15313–15316 (1998).
R. C. Blantz, J. Satriano, F. Gabbai, and C. J. Kelly, Acta Physiol. Scand., 168, 21–27 (2000).
A. Galea, S. Regunathan, V. Eliopoulos, et al., Biochem. J., 316, 247–249 (1996).
M. J. Lortie, W. F. Novotny, and O. W. Peterson, J. Clin. Invest., 97, 413–420 (1996).
D. Schwartz, O. W. Peterson, M. Mendonca, et al., Am. J. Physiol., 272, F597–F601 (1997).
D. J. Stuer, Annu. Rev. Pharmacol. Toxicol., 37, 339–359 (1997).
G. M. Boga, R. Singh, S. Pervin, et al., Am. J. Physiol., 271, 1988–1998 (1996).
G. Wu and C. J. Meininger, Am. J. Physiol., 269, 1312–1318 (1995).
V. G. Granik, Drugs: Pharmacological, Biochemical, and Chemical Aspects, [in Russian], Vuz. Kniga, Moscow (2001).
M. A. Creager, S. M. Gallagher, X. J. Giverd, et al., J. Clin. Invest., 90, 1248–1255 (1992).
J. L. Dubois, R. Zelinsky, F. Roudot, et al., Am. J. Cardiol., 70, 1269–1276 (1992).
H. G. Williams-Ashman and Z. N. Canellakis, Perspect. Biol. Med., 22, 421–453 (1979).
A. E. Pegg and P. P. McCann, Am. J. Physiol., 243, 212–221 (1982).
C. W. Tabor and H. Tabor, Annu. Rev. Biochem., 53, 749–790 (1984).
A. E. Pegg, Biochem. J., 234, 249–262 (1986).
C. W. Porter and J. R. Sufrin, Anticancer. Res., 6, 525–542 (1986).
J. Janne, E. Hollta, A. Kallio, et al., Spec. Top. Endocrinol. Metab., 5, 227–293 (1983).
P. P. McCann and A. E. Pegg, A Sjoerdsma, Biological Significance and Basis for New Therapies, Orlando, FL: Academic Press (1987), pp. 1–371.
A. E. Pegg, Cancer Res., 48, 759–774 (1988).
A. E. Pegg, R. S. Wechter, R. S. Clark, et al., Biochemistry, 25, 379–384 (1986).
A Sjoerdsma and P. J. Schechter, Clin. Pharmacol. Ther., 35, 287–300 (1984).
A. E. Pegg, K.-C. Tang, and J. K. Coward, Biochemistry, 21, 5082–5086 (1982).
A. E. Pegg, D. B. Jones, and J. A. Secrist, Biochemistry, 21, 5097–5102 (1982).
L. Alhonen-Hongisto, P. Seppanen, and J. Janne, Biochem. J., 192, 941–945 (1982).
A. Kallio, J. Janne, Biochem. J., 212, 895–901 (1983).
A. Kallio, P. Nikula, and J. Janne, Biochem. J, 218, 641–644 (1984).
V. A. Levin, M. C. Chamberlain, M. D. Prados, et al., Cancer Treat. Rep., 71, 459–465 (1987).
R. Scleiffer, B. Duranton, F. Gosse, et al., Nitric Oxide: Biol., Chem., 4, 583–589 (2000).
N. Seiler, C. L. Atanasov, and F. Raul, Int. J. Oncol., 13, 993–1006 (1998).
F. Blachier, A. Mignon, and O. Soubrane, Nitric Oxide: Biol., Chem., 1, 268–272 (1997).
J. Satriano, S. Ishizuka, D. C. Archer, et al., Am. J. Physiol., 276, C 892–899 (1999).
A. Al'bert, Specific Toxicity [Russian Translation], Meditsina, Moscow (1989), Vols. 1 and 2.
G. I. Zhungietu and V. G. Granik, Basic Principles of Drug Design [in Russian], Moldova State University, Kishinev (2000).
V. G. Granik, Principles of Medicinal Chemistry [in Russian], Vuz. Kniga, Moscow (2001).
J. G. Cannon, Pharmacology for Chemists, Oxford University Press, N. Y., Oxford (1999).
S. W. Porter, R. J. Bergeron, and N. J. Stolowich, Cancer Res., 42, 4072–4078 (1982).
S. W. Porter, P. F. Cavanaugh, N. J. Stolowich, et al., Cancer Res., 45, 2050–2056 (1985).
W. D. W. Heston, C.-R. Yang, L. Pliner, et al., Cancer Res., 47, 3627–3631 (1987).
D. A. Wooley, A Study of Antimetabolites, New York (1952).
R. A. Cosero, R. J. Bergeron, and S. W. Porter, J. Cell. Physiol., 121, 476–482 (1984).
K. A. Govern, P. S. Clark, and A. E. Pegg, J. Cell. Physiol., 127, 311–316 (1986).
S. W. Porter, B. Ganis, T. Vinson, et al., Cancer Res., 46, 6279–6285 (1986).
S. W. Porter, J. McManis, R. A. Casero, et al., Cancer Res., 47, 2821–2827 (1987).
B. G. Erwin and A. E. Pegg, Biochem. J, 238, 581–587 (1986).
R. Casero, B. Go, H. W. Theiss, et al., Cancer Res., 47, 3964–3967 (1987).
L. J. Marton, Pharmacol. Ther., 32, 183–190 (1987).
I. Sano, D. F. Deen, S. M. Oredsson, et al., Cancer Res., 44, 577–583 (1984).
L. J. Marton, V. A. Levin, S. J. Hervatin, et al., Cancer Res., 41, 4426–4433 (1981).
L. J. Marton, in: “Polyamine in Clinical Disorder” (D. F. Tierney, Moderator), West. J. Med., 142, 63–69 (1985).
J. Seidenfeld and R. K. A. Komar, Cancer Res., 45, 2132–2137 (1985).
A. V. Danilov, O. B. Romanova, I. K. Sorokina, et al., Vopr. Biol. Med. Farm. Khim., No. 2, 50–55 (2001).
J. M. Ducore and L. McNamara, Cancer Res., 46, 1068–1077 (1986).
M. A. Moore, H. Tsuda, T. Ogiso, et al., Cancer Lett., 25, 145–149 (1982).
T. Nakadate, E. Aizu, S. Yamamoto, et al., Jpn. J. Pharmacol., 37, 253–260 (1985).
R. A. Malt, A. N. Kingsnorth, G. M. Lamuraglia, et al., Adv. Enzym. Regul., 24, 93–97 (1985).
Y. Homma, S. Ozono, I. Numata, et al., Carcinogenesis (Lond.), 6, 159–166 (1985).
H. J. Thompson and A. M. Ronan, Carcinogenesis (Lond.), 7, 2003–2006 (1986).
N. D. Nigro, A. W. Bull, and M. E. Boyd, J. Natl. Cancer Inst., 77, 1309–1313 (1986).
G. D. Luk and S. B. Baylin, N. Engl. J. Med., 311, 80–87 (1984).
R. J. Moorehead, M. Hoper, and S. T. D. McKelvay, Br. J. Surg., 74, 364–368 (1987).
H. G. Williams-Ashman, J. Seidenfeld, and P. Galetti, Biochem. Pharmacol., 35, 1217–1224 (1982).
F. Schlenk, Adv. Enzymol., 54, 195–201 (1983).
H. Yamanaka, M. Kubota, D. A. Carson, Cancer Res., 47, 1771–1774 (1987).
P. S. Mamont, M.-C. Duchesne, J. Grove, et al., Exp. Cell. Res., 115, 387–392 (1978).
E. E. Medrano, O. R. Burrone, M. M. Ferrer, et al., FEBS Lett., 206, 106–108 (1986).
M. Carteni-Farina, G. Cacciapuoti, M. Porcelli, et al., Biochim. Biophys. Acta, 805, 158–167 (1984).
M. C. Pancaskie and D. D. Lakin, Biochem. Pharmacol., 36, 2063–2074 (1987).
T. M. Savarese, L. Y. Ghoda, and R. E. Park, In: Y.-C. Cheng, B. Goz, M. Mincoff (eds.), Development of Target Oriented Anticancer Drugs, Raven Press, New York (1983), pp. 129–142.
J. Loscalzo, Circulation, 101, 2126–2129 (2000).
N. Gocke, J. F. Keaney, B. Frei, et al., Circulation, 99, 3234–3239 (1999).
J. V. Mombouli, Drugs, 54(suppl. 5), 12–22 (1997).
M. A. Creager, S. M. Gallagher, X. J. Cirerd, et al., J. Clin. Invest., 90, 1248–1253 (1992).
J. L. Dubois-Rande, R. Zelinsky, F. Roudot, et al., Am. J. Cardiol., 70, 1269–1275 (1992).
M. T. Jay, S. Chirico, R. C. Siow, et al., Exp. Physiol., 82, 349–356 (1997).
K. Kikuta, T. Sawamura, S. Miwa, et al., Circ. Res., 83, 1088–1092 (1998).
H. Miuazaki, H. Matsuoka, J. P. Cooke, et al., Circulation, 99, 1141–1146 (1999).
D. Giuliano, R. Marfella, G. Verazzo, et al., J. Clin. Invest., 99, 433–438 (1997).
C. M. Giraldelo, A. Zappellini, N. N. Muscara, et al., Eur. J. Pharmacol., 257, 87–93 (1994).
J. P. F. Chin-Dusting, C. T. Alexander, P. J. Arnold, et al., J. Cardiovasc. Pharmacol., 28, 158–164 (1996).
A. Blum, L. Hathaway, L. Mincemoyer, et al., Circulation, 101, 2160–2166 (2000).
E. Stroes, J. Kastelein, F. Cosentino, et al., J. Clin. Invest., 99, 41–44 (1997).
G. M. Pieper, Hypertension, 31, 1047–1060 (1998).
V. Grill, O. Bjorkman, M. Gutniak, et al., Metabolism, 41, 28–34 (1992).
L. Hagenfeldt, G. Dahlquist, and B. Persson, Acta Pediatr. Scand., 794, 278–283 (1989).
T. C. Wascher, K. Posch, S. Wallner, et al., Biochem. Biophys. Res. Commun., 234, 35–38 (1997).
E. Brand and M. Sandberg, Organic Synth., Coll. Vol. II (1943), pp. 49–55.
K. Odo, J. Chem. Soc. Jpn., Pure Chem. Sect., 74, 774–778 (1953).
P. A. S. Smith, Organic Synth., Coll. Vol. IV (1963), pp. 819–824.
J. von Brown and W. Pinkernelle, Chem. Ber., 70, 1230–1237 (1937).
M. Israel, J. S. Rosenfield, and E. J. Modest, J. Med. Chem., 7(6), 710–718 (1964).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Granik, V.G. Metabolism of L-Arginine (A Review). Pharmaceutical Chemistry Journal 37, 111–127 (2003). https://doi.org/10.1023/A:1024578429137
Issue Date:
DOI: https://doi.org/10.1023/A:1024578429137